Drug–Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection

被引：0
|
作者：
Hala Mohsen Abdullatif
Rania Ramzi
Engy Adel Mogahed
Carolyne Morcos Ghobrial
Basma Abd El Rasheed Abd El Zaher
Mona S. El Raziky
Hanaa Mostafa El-Karaksy
机构：
[1] Cairo University Pediatric Hospital,Pediatric Hepatology Unit
[2] Kasr Alainy Drug Information Center,undefined
[3] Cairo University,undefined
来源：
Clinical Drug Investigation | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：857 / 864
页数：7
相关论文
共 50 条
  • [41] Treatment of hepatitis C virus recurrence after transplantation with sofosbuvir/ledipasvir: The role of ribavirin
    Globke, Brigitta
    Raschzok, Nathanael
    Teegen, Eva-Maria
    Pratschke, Johann
    Schott, Eckart
    Eurich, Dennis
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (01)
  • [42] Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection
    Yanny, Beshoy T.
    Latt, Nyan L.
    Saab, Sammy
    Han, Steven
    Choi, Gina
    Kramer, Jason
    Sahota, Amandeep K.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (10) : 908 - 912
  • [43] Identification of Predictors for Treatment Failure in Hepatitis C Virus Patients Treated With Ledipasvir and Sofosbuvir
    Jansen, Jeffrey W.
    Powderly, Gillian M.
    Linneman, Travis W.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (07) : 543 - 547
  • [44] Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
    Maria Pilar Ballester-Ferré
    Fernando Martínez
    Natalia Garcia-Gimeno
    Francisco Mora
    Miguel A Serra
    World Journal of Hepatology, 2017, (03) : 161 - 166
  • [45] Ledipasvir/sofosbuvir/vonoprazanRecurrence of hepatitis C virus secondary to treatment failure: case report
    Reactions Weekly, 2016, 1630 (1) : 154 - 154
  • [46] Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels
    Younossi, Z. M.
    Elsheikh, E.
    Stepanova, M.
    Gerber, L.
    Nader, F.
    Stamm, L. M.
    Brainard, D. M.
    McHutchinson, J. G.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (12) : 977 - 982
  • [47] Treatment of hepatitis C virus infection in intravenous drug users
    Cowan, Matthew L.
    Maxwell, James D.
    ACTA NEUROPSYCHIATRICA, 2006, 18 (05): : 183 - 192
  • [48] COST EFFECTIVENESS ANALYSIS OF SOFOSBUVIR AND LEDIPASVIR/SOFOSBUVIR IN HEPATITIS C VIRUS (HCV) PATIENTS
    Ruggeri, M.
    Romano, F.
    Cicchetti, A.
    VALUE IN HEALTH, 2016, 19 (07) : A513 - A513
  • [49] Ledipasvir/Sofosbuvir for 12 weeks is safe and effective in adolescents with chronic hepatitis C virus infection and hematological malignancies undergoing chemotherapy
    El-Sayed, M. H.
    Ebeid, F. S. E. S.
    Zekri, A. R.
    Massetto, B.
    Kersey, K.
    Osinusi, A.
    Zhang, F.
    Brainard, D.
    Elsayed, W.
    El-Haddad, A.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S515 - S515
  • [50] SUCCESSFUL THERAPY OF CHRONIC HEPATITIS C VIRUS INFECTION WITH SOFOSBUVIR AND LEDIPASVIR IN RENAL TRANSPLANT RECIPIENTS
    Guberina, H.
    Eisenberger, U.
    Willuweit, K.
    Bienholz, A.
    Kribben, A.
    Gerken, G.
    Witzke, O.
    Herzer, K.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 20 - 21
12345